{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:34:07Z","timestamp":1767836047326,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013041","name":"Shiraz University of Medical Sciences Vice Chancellor of Research","doi-asserted-by":"publisher","award":["17794"],"award-info":[{"award-number":["17794"]}],"id":[{"id":"10.13039\/501100013041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.gene.2025.149386","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T16:43:15Z","timestamp":1741711395000},"page":"149386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Investigation on the association between Osteopontin and Apolipoprotein E gene polymorphisms and vancomycin-induced acute kidney injury: A pharmacokinetic\/pharmacogenetic study in critically ill patients"],"prefix":"10.1016","volume":"952","author":[{"given":"Negar","family":"Firouzabadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorsa","family":"Karbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parisa","family":"Ghasemiyeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzaneh","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Alimoradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5976-6519","authenticated-orcid":false,"given":"Maryam","family":"Kavousi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1007-1422","authenticated-orcid":false,"given":"Soliman","family":"Mohammadi-Samani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gene.2025.149386_b0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.ajkd.2014.10.013","article-title":"Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management","volume":"65","author":"Akbari","year":"2015","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.gene.2025.149386_b0010","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/137072","article-title":"Mediators of inflammation in acute kidney injury","volume":"2009","author":"Akcay","year":"2009","journal-title":"Mediators Inflamm."},{"issue":"11","key":"10.1016\/j.gene.2025.149386_b0015","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/cid\/ciz051","article-title":"Vancomycin area under the curve and acute kidney injury: a meta-analysis","volume":"69","author":"Aljefri","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.gene.2025.149386_b0020","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.2337\/diabetes.49.12.2190","article-title":"APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies","volume":"49","author":"Araki","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.gene.2025.149386_b0025","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00228-016-2079-0","article-title":"Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial","volume":"72","author":"Bahramali","year":"2016","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.gene.2025.149386_b0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/10641963.2016.1267196","article-title":"Association of renin\u2013angiotensin\u2013aldosterone system gene polymorphisms with left ventricular hypertrophy in patients with heart failure with preserved ejection fraction: a case\u2013control study","volume":"39","author":"Bahramali","year":"2017","journal-title":"Clin. Exp. Hypertens."},{"issue":"10","key":"10.1016\/j.gene.2025.149386_b0035","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/jac\/dkaa184","article-title":"Relationship of vancomycin trough levels with acute kidney injury risk: an exposure\u2013toxicity meta-analysis","volume":"75","author":"Bellos","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.gene.2025.149386_b0040","unstructured":"Beringer P., 2018. Winter's Basic Clinical Pharmacokinetics Wolters Kluwer."},{"issue":"12","key":"10.1016\/j.gene.2025.149386_b0045","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1128\/AAC.00168-11","article-title":"Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial","volume":"55","author":"Bosso","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.gene.2025.149386_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-020-00354-2","article-title":"The risk of vancomycin toxicity in patients with liver impairment","volume":"19","author":"Brunetti","year":"2020","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"issue":"4","key":"10.1016\/j.gene.2025.149386_b0055","first-page":"694","article-title":"The use of vancomycin with its therapeutic and adverse effects: a review","volume":"19","author":"Bruniera","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.gene.2025.149386_b0060","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/SHK.0000000000000721","article-title":"Osteopontin blockade attenuates renal injury after ischemia reperfusion by inhibiting NK cell infiltration","volume":"47","author":"Cen","year":"2017","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.gene.2025.149386_b0065","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/FPC.0000000000000182","article-title":"Genetic diversity of variants involved in drug response and metabolism in Sri Lankan populations: implications for clinical implementation of pharmacogenomics","volume":"26","author":"Chan","year":"2016","journal-title":"Pharmacogenet. Genomics"},{"issue":"52","key":"10.1016\/j.gene.2025.149386_b0070","doi-asserted-by":"crossref","first-page":"49142","DOI":"10.1074\/jbc.M104879200","article-title":"A protective role for kidney apolipoprotein E: regulation of mesangial cell proliferation and matrix expansion","volume":"276","author":"Chen","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.gene.2025.149386_b0075","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.2337\/diacare.16.10.1376","article-title":"Predictors of microalbuminuria in individuals with IDDM: Pittsburgh Epidemiology of Diabetes Complications Study","volume":"16","author":"Coonrod","year":"1993","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.gene.2025.149386_b0080","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/toxsci\/kfn203","article-title":"Gene expression analysis reveals new possible mechanisms of vancomycin-induced nephrotoxicity and identifies gene markers candidates","volume":"107","author":"Dieterich","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.gene.2025.149386_b0085","article-title":"Osteopontin and fatty acid binding protein (FABP), as biomarkers of cyclophosphamide nephrotoxicity, in an experimental model of cystitis in rats","volume":"73","author":"Dobrek","year":"2019","journal-title":"Advances in Hygiene & Experimental Medicine\/postepy Higieny i Medycyny Doswiadczalnej."},{"issue":"8","key":"10.1016\/j.gene.2025.149386_b0090","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1007\/s11033-013-2596-1","article-title":"Gender specificity of a genetic variant of angiotensin-converting enzyme and risk of coronary artery disease","volume":"40","author":"Firouzabadi","year":"2013","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.gene.2025.149386_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18433\/J3W31F","article-title":"Beta adrenoceptor polymorphism and clinical response to sertraline in major depressive patients","volume":"20","author":"Firouzabadi","year":"2017","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.gene.2025.149386_b0100","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2147\/NDT.S250141","article-title":"Orexin\/Hypocretin Type 2 Receptor (HCRTR2) gene as a candidate gene in sertraline-associated insomnia in depressed patients","volume":"16","author":"Firouzabadi","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.gene.2025.149386_b0105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/neu.2021.32","article-title":"Impact of ACE2 genetic variant on antidepressant efficacy of SSRIs","volume":"34","author":"Firouzabadi","year":"2022","journal-title":"Acta Neuropsychiatrica."},{"issue":"6","key":"10.1016\/j.gene.2025.149386_b0110","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4103\/1735-5362.301337","article-title":"A simple and validated HPLC method for vancomycin assay in plasma samples: the necessity of TDM center development in Southern Iran","volume":"15","author":"Ghasemiyeh","year":"2020","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.gene.2025.149386_b0115","article-title":"A brief review of pharmacokinetic assessments of vancomycin in special groups of patients with altered pharmacokinetic parameters","author":"Ghasemiyeh","year":"2022","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.gene.2025.149386_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.912202","article-title":"Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity prediction using individualized pharmacokinetic parameters","volume":"13","author":"Ghasemiyeh","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.gene.2025.149386_b0125","article-title":"Volume of distribution as an early predictor of vancomycin-induced AKI in critically ill patients","volume":"94","author":"Ghasemiyeh","year":"2023","journal-title":"Acta Bio Medica: Atenei Parmensis."},{"issue":"9","key":"10.1016\/j.gene.2025.149386_b0130","first-page":"379","article-title":"Vancomycin nephrotoxicity: myths and facts","volume":"69","author":"Gupta","year":"2011","journal-title":"Neth. J. Med."},{"issue":"6","key":"10.1016\/j.gene.2025.149386_b0135","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/AAC.6.6.722","article-title":"On the mechanism of action of vancomycin: inhibition of peptidoglycan synthesis in Gaffkya homari","volume":"6","author":"Hammes","year":"1974","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.gene.2025.149386_b0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neulet.2006.08.082","article-title":"Effect of APOE polymorphisms on early responses to traumatic brain injury","volume":"408","author":"Jiang","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"3\u20134","key":"10.1016\/j.gene.2025.149386_b0145","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.molimm.2013.01.013","article-title":"Kidney injury molecule-1 and osteopontin: new markers for prediction of early kidney transplant rejection","volume":"54","author":"Jin","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.gene.2025.149386_b0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00011-018-1200-5","article-title":"The role of osteopontin in kidney diseases","volume":"68","author":"Kaleta","year":"2019","journal-title":"Inflamm. Res."},{"issue":"4","key":"10.1016\/j.gene.2025.149386_b0155","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3390\/ijms23042052","article-title":"Vancomycin-associated acute kidney injury: a narrative review from pathophysiology to clinical application","volume":"23","author":"Kan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.gene.2025.149386_b0160","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/jcpt.12995","article-title":"A new population pharmacokinetic model for vancomycin in patients with variable renal function: therapeutic drug monitoring based on extended covariate model using CKD\u2010EPI estimation","volume":"44","author":"Kim","year":"2019","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.gene.2025.149386_b0165","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jcrc.2017.11.019","article-title":"Genetic variants and acute kidney injury: a review of the literature","volume":"44","author":"Larach","year":"2018","journal-title":"J. Crit. Care"},{"issue":"6","key":"10.1016\/j.gene.2025.149386_b0170","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/0897190014546114","article-title":"Vancomycin nephrotoxicity: a review","volume":"27","author":"Mergenhagen","year":"2014","journal-title":"J. Pharm. Pract."},{"issue":"1","key":"10.1016\/j.gene.2025.149386_b0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1176\/appi.neuropsych.16120322","article-title":"Glucocorticoid receptor genetic variants and response to fluoxetine in major depressive disorder","volume":"30","author":"Nouraei","year":"2018","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.gene.2025.149386_b0180","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1046\/j.1523-1755.1999.07107.x","article-title":"Apolipoprotein E polymorphism and renal disease","volume":"56","author":"Oda","year":"1999","journal-title":"Kidney Int."},{"issue":"14","key":"10.1016\/j.gene.2025.149386_b0185","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.3390\/jcm10143039","article-title":"Genetic susceptibility to acute kidney injury","volume":"10","author":"Ortega-Loubon","year":"2021","journal-title":"J. Clin. Med."},{"issue":"5","key":"10.1016\/j.gene.2025.149386_b0190","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.ajkd.2013.02.349","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury","volume":"61","author":"Palevsky","year":"2013","journal-title":"Am. J. Kidney Dis."},{"issue":"12","key":"10.1016\/j.gene.2025.149386_b0195","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2215\/CJN.00150118","article-title":"Pharmacology behind common drug nephrotoxicities","volume":"13","author":"Perazella","year":"2018","journal-title":"Clin. J. American Soc. Nephrol.: CJASN"},{"key":"10.1016\/j.gene.2025.149386_b0200","doi-asserted-by":"crossref","unstructured":"Poston-Blahnik, A., Moenster, R. (Eds.), 2021. Association between vancomycin area under the curve and nephrotoxicity: a single center, retrospective cohort study in a veteran population. Open forum infectious diseases. Oxford University Press US.","DOI":"10.1093\/ofid\/ofab094"},{"issue":"3","key":"10.1016\/j.gene.2025.149386_b0205","first-page":"1230","article-title":"Association of warfarin therapy with APOE and VKORC1 genes polymorphism in Iranian population","volume":"16","author":"Rafiee","year":"2017","journal-title":"Iranian Journal of Pharmaceutical Research: IJPR"},{"issue":"6","key":"10.1016\/j.gene.2025.149386_b0210","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/1055-9965.EPI-06-1008","article-title":"The role of osteopontin in tumor progression and metastasis in breast cancer","volume":"16","author":"Rodrigues","year":"2007","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"2","key":"10.1016\/j.gene.2025.149386_b0215","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.kint.2019.10.031","article-title":"Apolipoprotein E\u2013related glomerular disorders","volume":"97","author":"Saito","year":"2020","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.gene.2025.149386_b0220","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2217\/pgs.11.93","article-title":"Pharmacogenetic analyses of cisplatin-induced nephrotoxicity indicate a renoprotective effect of ERCC1 polymorphisms","volume":"12","author":"Tzvetkov","year":"2011","journal-title":"Pharmacogenomics"},{"issue":"15","key":"10.1016\/j.gene.2025.149386_b0225","doi-asserted-by":"crossref","first-page":"5568","DOI":"10.3390\/ijms21155568","article-title":"Osteopontin: The molecular bridge between fat and cardiac\u2013renal disorders","volume":"21","author":"Vianello","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2\u20133","key":"10.1016\/j.gene.2025.149386_b0230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tox.2007.12.031","article-title":"Validation of putative genomic biomarkers of nephrotoxicity in rats","volume":"246","author":"Wang","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.gene.2025.149386_b0235","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00228-016-2140-z","article-title":"FOXP3 rs3761548 polymorphism is associated with tacrolimus-induced acute nephrotoxicity in renal transplant patients","volume":"73","author":"Wu","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"23","key":"10.1016\/j.gene.2025.149386_b0240","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1097\/00029330-200712010-00011","article-title":"Osteopontin gene polymorphism in association with systemic lupus erythematosus in Chinese patients","volume":"120","author":"Xu","year":"2007","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"1","key":"10.1016\/j.gene.2025.149386_b0245","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/antibiotics11010112","article-title":"The serum concentration of vancomycin as a diagnostic predictor of nephrotoxic acute kidney injury in critically ill patients","volume":"11","author":"Zamoner","year":"2022","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.gene.2025.149386_b0250","doi-asserted-by":"crossref","first-page":"2","DOI":"10.53388\/IDR20200713002","article-title":"Effects of the ABCB1 genetic polymorphism on vancomycin blood concentration in critically ill patients of Chinese","volume":"1","author":"Zhao","year":"2020","journal-title":"Infect. Diseases Res."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811192500174X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037811192500174X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T21:11:51Z","timestamp":1744233111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037811192500174X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":50,"alternative-id":["S037811192500174X"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2025.149386","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation on the association between Osteopontin and Apolipoprotein E gene polymorphisms and vancomycin-induced acute kidney injury: A pharmacokinetic\/pharmacogenetic study in critically ill patients","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2025.149386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149386"}}